Biotech

All Articles

BioMarin halts preclinical gene treatment for heart disease

.After BioMarin conducted a spring clean of its pipeline in April, the firm has decided that it like...

Eisai plants molecular glue SEED with $1.5 B biobucks work

.Big Pharmas continue to be stuck to the idea of molecular glue degraders. The current company to ob...

Life scientific research credit scores firm introduces along with $600M

.A brand-new worldwide lifestyle science credit scores organization, termed Symbiotic Financing, has...

BMS trenches TIGIT, walking away from $200M bet on Agenus bispecific

.Bristol Myers Squibb is axing yet another huge bet coming from the Caforio age, canceling a bargain...

Nuvation stops BET prevention after looking at stage 1 data

.After taking a look at phase 1 data, Nuvation Bio has actually made a decision to halt work on its ...

' Medical intuition' led FDA experts to back Zevra's unusual health condition med

.Zevra Rehabs' uncommon illness medication seems to become on the path to confirmation this autumn a...

Pfizer takes $230M attacked after axing fell short DMD gene therapy

.Pfizer's stage 3 Duchenne muscle dystrophy (DMD) genetics therapy breakdown has blown a $230 thousa...

AC Immune observes 'site' potential in Alzheimer's medication data

.After much more than twenty years of deal with neurodegenerative conditions, Swiss biotech a/c Immu...

GSK drops ph. 2 HPV injection over shortage of best-in-class possible

.GSK has actually broken up a phase 2 human papillomavirus (HPV) vaccination from its pipe after det...

OS Treatments refiles $6M IPO to finance HER2 medication, preclinical ADCs

.Operating system Therapies will certainly detail on the NYSE American inventory swap this morning b...